FDA symptoms booklet while GH is authorised; off-label use requires robust evidence, cautious tracking

https://tr.ee/6V2HgukIgq

FDA symptoms guideline while GH is accepted; off-label use calls for mighty proof, cautious tracking, and clear consent discussions.